Show simple item record

dc.contributor.authorHalvorsen, Peder Andreas
dc.contributor.authorAasland, Olaf Gjerløw
dc.contributor.authorKristiansen, Ivar Sønbø
dc.date.accessioned2015-10-07T08:30:29Z
dc.date.available2015-10-07T08:30:29Z
dc.date.issued2015-07-03
dc.description.abstractBackground: Guidelines for primary prevention of cardiovascular disease provide little guidance on how patients’ preferences should be taken into account. We wanted to explore whether general practitioners (GPs) are sensitive to patient preferences regarding survival gains from statin therapy. Methods: In a cross sectional, online survey 3,270 Norwegian GPs were presented with a 55 year old patient with an unfavourable cardiovascular risk profile. He expressed preferences for statin therapy by indicating a minimum survival gain that would be considered a substantial benefit. This survival gain varied across six versions of the vignette: 8, 4 and 2 years, and 12, 6 and 3 months, respectively. Participants were randomly allocated to one version only. We asked whether the GPs would recommend the patient to take a statin. Subsequently we asked the GPs to estimate the average survival gain of life long simvastatin therapy for patients with a similar risk profile. Results: We received 1,296 responses (40 %). Across levels of survival gains (8 years to 3 months) the proportion of GPs recommending statin therapy did not vary significantly (OR per level 1.07, 95 % CI 0.99 to 1.16). The GP’s own estimate of survival gain was a statistically significant predictor of recommending therapy (OR per year adjusted for the GPs’ age, sex, speciality attainment and number of patients listed 3.07, CI 2.55 to 3.69). Conclusion: GPs were insensitive to patient preferences regarding survival gain when recommending statin therapy. The GPs' recommendations were strongly associated with their own estimates of survival gainen_US
dc.description.sponsorshipThe costs of data collection were covered by a grant from the Norwegian Research Council. The funding source had no role in the design, collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.en_US
dc.identifier.citationBMC Family Practice (2015) 16:79en_US
dc.identifier.cristinIDFRIDAID 1252488
dc.identifier.doi10.1186/s12875-015-0288-8
dc.identifier.issn1471-2296
dc.identifier.urihttps://hdl.handle.net/10037/8197
dc.identifier.urnURN:NBN:no-uit_munin_7778
dc.language.isoengen_US
dc.publisherBioMed Centralen_US
dc.rights.accessRightsopenAccess
dc.subjectprimary preventionen_US
dc.subjectcardiovascular diseaseen_US
dc.subjectpatients’ preferencesen_US
dc.subjectsurvival gainsen_US
dc.subjectstatin therapyen_US
dc.subjectGP recommendationsen_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Community medicine, Social medicine: 801en_US
dc.titleDecisions on statin therapy by patients’ opinions about survival gains: cross sectional survey of general practitionersen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record